Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Acetazolamide (Primary) ; OBX 115 (Primary) ; Cyclophosphamide; Fludarabine; Furosemide; Mesna
- Indications Malignant melanoma; Solid tumours
- Focus Adverse reactions; First in man
- 04 Jun 2024 Results (n=9) presented at the 60th Annual Meeting of the American Society of Clinical Oncology.
- 03 Jun 2024 According to Obsidian Therapeutics media release, data from the study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 03 Jun 2024 Results published in the Obsidian Therapeutics Media Release